查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1856247

痔瘡治療器材市場：依產品類型、最終用戶、通路及支付方類型分類－2025年至2032年全球預測

Hemorrhoid Treatment Devices Market by Product Type, End User, Distribution Channel, Payer Type - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，痔瘡治療器材市場規模將達到 12.7525 億美元，複合年成長率為 6.02%。

關鍵市場統計數據
基準年 2024 7.9889億美元
預計年份：2025年 8.4711億美元
預測年份 2032 1,275,250,000 美元
複合年成長率 (%) 6.02%

本文簡要介紹了痔瘡治​​療方法在臨床和商業層面上的變化，包括器械的多樣性、治療環境的變化以及患者的期望。

痔瘡治療器材的研發融合了臨床需求、技術主導和不斷變化的醫療服務模式。近年來，臨床醫生越來越傾向於選擇微創治療方案，以縮短恢復時間並實現門診治療。器械研發者也積極回應，推出了包括冷凍療法、雷射療法、紅外線凝固療法、橡皮筋結紮術和硬化療法在內的多種治療平台。這種多樣化反映了器械工程技術的進步，以及對治療過程中手術耐受性、病患滿意度和成本控制的日益重視。

臨床實踐模式正隨著患者期望的演變而不斷發展。曾經以傳統切除術為主的傳統外科手術正逐漸被微創手術所取代，這些微創手術可以在門診手術中心、醫生診所甚至居家醫療機構按照既定流程進行。同時，支付方的嚴格審查和醫院採購動態，促使人們對可靠的臨床證據和易於理解的定價提出更高的要求，從而推動供應商優先考慮療效數據、簡化的培訓項目和耗材成本控制。

因此，價值鏈上的相關人員在調整各自的策略：臨床醫生正在改進治療流程，醫院和門診中心正在評估資本和耗材的經濟效益，而醫療器材製造商則正在加快產品改進和上市後證據的收集。本報告的引言部分為深入分析影響痔瘡治療器材市場的臨床促進因素、技術路徑和商業性影響奠定了基礎。

臨床預期、監管政策的明確性、供應鏈的韌性以及數位化支援工具的融合如何推動痔瘡治療器材創新進入新時代

來自臨床醫生、支付方和患者的共同壓力正在改變痔瘡治療器材的格局。技術進步使微創手術更加穩定和便捷，這體現在能量傳輸系統、器械人體工學以及耗材設計的改進等方面。因此，曾經僅限於醫院手術室的器械正擴大被引入門診手術中心和診所，從而提高了手術效率並降低了單次手術成本。

不斷變化的監管和報銷政策進一步加速了變革。監管機構正在為醫療器材的漸進式改善掃清障礙，而支付方則更傾向於那些能夠減少後續資源消耗的手術。這促使製造商增加對上市後監測和基於價值的證據的投入，以證明其產品能夠縮短恢復時間並降低併發症率。同時，訓練模式也在轉變，旨在縮短新技術的普及應用週期，包括模組化課程、虛擬模擬和肛腸科專項技能提升訓練。

供應鏈韌性和零件採購也正在發生關鍵性變化。製造商正在實現供應商多元化，並探索本地化生產，以降低地緣政治風險和關稅的影響。同時，遠端監測、遠距會診和患者互動平台等數位化工具開始在術前評估和術後追蹤中發揮輔助作用，重新定義了患者和臨床醫師的手術全期體驗。

2025 年的關稅調整迫使製造商和買家重組供應鏈，重新優先考慮國內採購，並重新談判整個生態系統的籌資策略。

美國2025年關稅的實施對痔瘡治療器械生態系統產生了廣泛而顯著的影響。對於依賴進口零件的製造商而言，例如雷射系統的高精度光學元件、冷凍療法的專用壓縮機和氣體，以及橡皮筋結紮術中使用的特殊一次性分配器，額外的關稅增加了到岸成本，並促使他們迅速重新評估籌資策略。為此，許多供應商加快了供應商多元化，尋求透過其他關稅分類獲得關稅減免，並積極尋求與本地製造商建立夥伴關係，以減少淨利率下降。

這些成本壓力波及整個通路。醫院採購團隊加強了對耗材價格和服務合約的談判，一些門診中心則傾向於選擇耗材需求較低或國內供應更充足的設備。支付方和採購聯盟也隨之更仔細地審查每件設備的成本，這反過來又影響了產品定位和促銷策略。更重要的是，關稅環境的變化調整了產品的上市和升級計劃，製造商優先考慮供應鏈透明度更高的產品。

創新議程和市場推廣計劃也隨之調整。擁有強大的區域內製造和組裝能力的公司在產品上市速度和價格穩定性方面獲得了優勢，而規模較小的製造商則轉向契約製造和授權許可，以維持市場進入。總體而言，關稅政策的變化凸顯了供應鏈敏捷性、成本模型的精細化以及與醫院、診所和分銷合作夥伴等採購相關人員積極互動的重要性。

透過整合產品、最終用戶、分銷管道和支付方等差異進行細分分析，揭示臨床、物流和商業性影響。

產品細分揭示了多種治療方法和設備架構，每種方法和架構都具有獨特的臨床和商業性意義。根據產品類型，市場可分為冷凍治療設備、痔瘡切除設備、紅外線凝固設備、雷射治療設備、橡皮筋結紮器和硬化治療設備。對於冷凍治療，基於氣體壓縮的系統和基於液態氮的平台之間的差異會影響物流、耗材需求和治療部位的相容性。痔瘡切除設備種類繁多，從結紮桿、縫合器到傳統手術刀，由於手術複雜程度、手術時間和術後結果的差異，導致醫院和外科醫生的選擇各不相同。紅外線凝固設備分為接觸式和非接觸式，而雷射治療設備包括二氧化碳雷射、二極體雷射和Nd:YAG雷射設備，每種設備都有不同的組織交互作用特性和資本投入。橡皮筋結紮器種類繁多，從一次性到多環、可重複使用和單頻段分配器，影響手術成本和感染控制流程。硬化療法設備根據其使用的注射器分為乙氧基硬化劑和聚多卡醇注射器，這種區別影響臨床操作、濃度選擇和監管方面的考慮。

終端用戶細分有助於了解市場推廣壓力和投資的集中方向。根據終端用戶，市場可分為門診手術中心、診所、居家醫療保健機構和醫院。門診手術中心又可細分為醫院所有和醫生所有，二者的資本核准流程和產能獎勵各不相同。診所分為普通診所和肛門腸科診所，其手術組合因專科專長和轉診模式而異。居家醫療提供護理人員管理和病人自主管理兩種模式，凸顯了人們對以病人為中心、較為簡單的介入措施日益成長的興趣。公立和私立醫院仍然是重症病例和早期採用資本密集平台的主要場所。

分銷管道和支付方細分有助於了解醫療服務取得和報銷的動態。根據分銷管道，市場可分為直銷、醫院採購、線上藥房和零售藥房，這些管道決定了醫療器材和耗材如何到達臨床醫生和患者手中。根據支付方類型，市場可分為政府保險、自費和私人保險。政府保險進一步細分為醫療補助計劃 (Medicaid) 和醫療保險 (Medicare)，而自費則細分為援助項目和自費。這些細分層級闡明了它們在臨床應用、定價和報銷方面的參與如何影響商業性成功。

美洲、歐洲、中東和非洲以及亞太地區的監管、報銷和生產動態將如何影響其普及和商業化

區域動態導致技術採納、證據要求和商業策略的路徑各不相同，這些路徑受到法律規範、支付模式和臨床實踐模式的影響。在美洲，醫院系統和門診手術中心正在積極推動微創平台的早期應用，這些平台具有已被證實的成本優勢，並符合機構的效率目標。與大型集團採購組織和整合醫療服務網路的密切關係也會影響合約簽訂和定價談判。

在歐洲、中東和非洲，儘管部分市場的監管協調正在推進，但分散的報銷體系迫使製造商尋求有針對性的臨床證據和特定國家的價值證明。在一些歐洲、中東和非洲市場，國家採購計畫和集中競標正在支持具有成本競爭力的耗材模式，而在其他市場，私人醫院和專科診所則在推動高階能量型醫療器材的普及。

亞太地區成熟與快速發展的醫療保健體系並存，這不僅為大規模推廣應用創造了機遇，也為創新型經銷夥伴提供了可能。該地區的製造能力和本地供應鏈既支持出口導向型生產，也支持本地組裝，從而減輕關稅影響，並提高對需求波動的應對力。過渡語：這些區域特徵共同意味著，打入市場策略必須根據當地報銷制度、採購機制和臨床指南的採納速度進行調整。

臨床倡導、模組化創新、策略夥伴關係和整合服務模式的競爭動態將決定差異化和市場佔有率。

競爭格局正在形成平衡，既有根深蒂固的供應商，也有注重利基創新、耗材經濟和服務模式的敏捷挑戰者。主要企業正大力投資臨床證據的產生和用戶培訓，以降低產品推廣門檻；而新興企業則專注於模組化設備、一次性耗材和數位化增強，以實現產品差異化。策略夥伴關係、共同開發契約和選擇性授權協議是企業在無需承擔垂直整合所帶來的資本負擔的情況下拓展產品組合的常見途徑。

領先企業將強大的臨床支援與靈活的商業模式相結合，提供試用項目、耗材捆綁定價和一體化維護服務。他們還優先考慮售後服務支援和在地化培訓，以縮短外科醫生和診所工作人員的學習曲線。此外，強大的供應鏈網路和區域組裝設施也為他們在受關稅波動和物流限制影響的市場中提供了競爭優勢。

最後，併購活動以及對能量輸送模組、一次性應用器和遠端醫療追蹤解決方案等相關技術的定向投資，顯示企業致力於拓展臨床效用，並獲取圍繞手術的更多價值鏈佔有率。這些策略舉措反映出，市場差異化日益依賴將設備效能、臨床結果和總醫療成本結合的整合解決方案。

為製造商和相關人員提供切實可行的策略建議，以協調產品設計、證據產生、分銷和供應鏈韌性，從而實現持續的市場成功。

為確保永續的競爭優勢，產業領導者應優先考慮多管齊下的策略，將產品設計、證據產生和商業性執行有機結合。首先，產品開發應著重於降低手術複雜性和耗材消耗，同時維持或改善臨床療效，促進產品在門診和診所的廣泛應用。同時，應投資可操作的臨床試驗和真實世界證據，以證明產品能夠縮短恢復時間、減少併發症並降低後續治療的使用，從而滿足支付方和採購委員會的要求。

其次，重新設計分銷和定價模式，使其更符合醫療保健產業的經濟法則。提供靈活的合約、耗材組合和試驗計畫，以減少門診手術中心、醫生營運的醫療機構和診所的採用阻力。儘早與醫院採購部門接洽，就總體擁有成本達成一致，並協商包含培訓和維護在內的服務水準協議。

第三，我們將透過多元化零件供應商、推進區域組裝以及探索創新性的關稅減免策略來增強供應鏈韌性。第四，我們將建立可擴展的培訓和數位化支援計畫（虛擬模擬、手術庫、遠距教學），以加快臨床醫生技能提升並增強產品忠誠度。最後，我們將尋求夥伴關係，以擴大臨床適應症並整合互補技術，並積極與監管機構和支付方溝通，以製定有利的推廣路徑和報銷核准。

我們採用透明的混合方法研究途徑，結合專家訪談、二手證據綜合和三角驗證，以提供可複製的策略見解。

本報告的研究結合了質性訪談、二手資料綜合和嚴謹的三角驗證法，以確保其可靠性和情境相關性。主要研究包括對臨床專家、採購負責人、門診中心經理和設備主管進行結構化訪談，以了解目前的實踐模式、採購重點和創新藍圖。這些訪談內容用於主題編碼，以突顯臨床促進因素、推廣障礙和未滿足的服務需求。

這項二次研究整合了同行評審的臨床文獻、官方監管文件、產品手冊和公司披露資訊，以驗證技術聲明並檢驗設備功能圖譜。分析採用了交叉驗證技術，以協調來自不同資訊來源的觀點，並識別不同地區和終端用戶類型中的一致訊號。此外，專家審查了研究結果草案，以發現事實差距並確定其對商業化和臨床應用的實際意義。

在適用情況下，我們會考慮主要准入方面的限制因素，例如獨特的合約條款和條件或快速變化的關稅框架。我們運用敏感度分析和情境評估來減輕這些限制。本調查方法強調透明度、可重複性以及證據來源與分析結論之間的清晰聯繫，從而為可靠的策略決策提供支持。

策略結論強調，要獲得長期應用，需要以證據主導的創新、適應性商業化和供應鏈敏捷性為特徵。

總之，痔瘡治療器材產業正經歷一場重大變革，其驅動力包括技術的多元化、治療部位偏好的改變以及對成本效益日益成長的期望。微創治療方法和耗材高效的器械越來越受歡迎，因為臨床醫生和購買者都在尋求能夠縮短恢復時間和減少後續資源消耗的治療方法。同時，供應鏈動態和關稅趨勢也凸顯了生產彈性和精細化定價策略的重要性。

將產品創新與可靠的臨床證據、靈活的商業模式和穩定的採購管道相結合的製造商，將最有利於在醫院、門診手術中心、診所和居家醫療機構中實現產品的長期應用。策略性地關注臨床醫生培訓、支付方參與和整合服務交付，將加速產品應用並促進長期夥伴關係的建立。最終，那些能夠將臨床信譽與實際營運執行相結合，以滿足醫療服務提供者和患者不斷變化的需求的機構，將取得最大的成功。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 門診痔瘡治療中一次性射頻消融設備的採用率不斷提高
  • 擴大非處方局部乳霜套件的規模，其中添加了生物合成聚合物密封劑，可緩解症狀。
  • 將人工智慧主導的成像和診斷工具整合到微創痔瘡治療設備中
  • 增加對藥物塗層縫合器系統的投資，該系統將手術切除與局部藥物輸送相結合。
  • 以病人為中心的遠端醫療平台和指導式家庭痔瘡結紮系統的出現

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 痔瘡治療器材市場（依產品類型分類）

  • 冷凍療法設備
    • 氣體壓縮基地
    • 液態氮基地
  • 痔瘡切除器械
    • 索具設備
    • 訂書機
    • 傳統手術刀
  • 紅外線凝血裝置
    • 接觸式紅外線凝固
    • 非接觸式紅外線凝固
  • 雷射治療設備
    • 二氧化碳雷射設備
    • 二極體雷射設備
    • Nd:YAG雷射設備
  • 橡皮筋結紮器
    • 一次性分配器
    • 多頻段分配器
    • 可重複使用分配器
    • 單頻段分配器
  • 硬化療法設備
    • 乙氧基硬脂醇注射器
    • 聚多卡醇注射器

第9章 痔瘡治療器材市場（依最終用戶分類）

  • 門診手術中心
    • 醫院所屬的門診手術中心
    • 醫生營運的門診手術中心
  • 診所
    • 一般診所
    • 直腸科診所
  • 居家照護
    • 護理師管理
    • 自我管理
  • 醫院
    • 私立醫院
    • 公立醫院

第10章 痔瘡治療器材市場（依分銷管道分類）

  • 直銷
  • 醫院採購
  • 網路藥房
  • 零售藥房

第11章 依支付方類型分類的痔瘡治療器材市場

  • 政府保險
    • 醫療補助
    • 聯邦醫療保險
  • 自費
    • 補貼計劃
    • 自費
  • 私人保險
    • 雇主出資計劃
    • 個人計劃

第12章 痔瘡治療器材市場：依地區分類

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 痔瘡治療器材市場（依類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國痔瘡治療器材市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Johnson & Johnson
    • Medtronic plc
    • B. Braun Melsungen AG
    • CONMED Corporation
    • Teleflex Incorporated
    • Olympus Corporation
Product Code: MRR-450A0628DDAC

The Hemorrhoid Treatment Devices Market is projected to grow by USD 1,275.25 million at a CAGR of 6.02% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 798.89 million
Estimated Year [2025] USD 847.11 million
Forecast Year [2032] USD 1,275.25 million
CAGR (%) 6.02%

A concise clinical and commercial introduction framing how device diversity, care setting shifts, and patient expectations are reshaping hemorrhoid treatment approaches

Hemorrhoid treatment devices occupy an intersection of clinical necessity, technology-driven innovation and shifting care delivery models. Over recent years, clinicians have increasingly prioritized minimally invasive options that reduce recovery time and enable outpatient management, while device developers have responded with diversified platforms spanning cryotherapy, laser, infrared coagulation, rubber band ligation and sclerotherapy. This diversification reflects both advances in device engineering and a broader emphasis on procedure tolerability, patient satisfaction and cost containment within care pathways.

Clinical practice patterns are evolving in parallel with patient expectations. Where traditional excisional techniques once dominated, there is growing adoption of less invasive modalities that can be performed in ambulatory surgical centers, clinics or even home care settings under defined protocols. At the same time, payer scrutiny and hospital procurement dynamics drive demand for robust clinical evidence and straightforward cost-of-care narratives, encouraging vendors to prioritize outcomes data, streamlined training programs and consumable cost control.

Consequently, stakeholders across the value chain are recalibrating strategy: clinicians refine treatment algorithms, hospitals and ambulatory centers evaluate capital versus disposable economics, and device manufacturers accelerate product refinement and post-market evidence generation. This report introduction sets the stage for a deeper analysis of the clinical drivers, technology pathways and commercial implications shaping the hemorrhoid treatment devices landscape.

How converging clinical expectations, regulatory clarity, supply chain resilience, and digital support tools are catalyzing a new era of hemorrhoid device innovation

The landscape for hemorrhoid treatment devices has undergone transformative shifts driven by converging pressures from clinicians, payers and patients. Technological refinement has made minimally invasive procedures more consistent and accessible, rising from improvements in energy delivery systems and instrument ergonomics to better consumable design. As a result, devices once confined to hospital operating rooms increasingly migrate to ambulatory surgical centers and outpatient clinics, enabling faster throughput and lower per-procedure costs.

Regulatory and reimbursement evolutions further accelerate change. Regulators have clarified pathways for incremental device enhancements, while payers have signaled preferences for procedures with demonstrable reductions in downstream resource use. This has encouraged manufacturers to invest in post-market studies and value-based evidence that substantiate shorter recovery periods and reduced complication rates. In parallel, the training paradigm has shifted toward modular curricula, virtual simulation and proctology-focused upskilling that shorten adoption curves for new technologies.

Supply chain resilience and component sourcing also represent a pivotal shift. Manufacturers are diversifying suppliers and exploring regional manufacturing to mitigate geopolitical risk and tariff exposure. Concurrently, digital tools such as remote monitoring, teleconsultation and patient engagement platforms are beginning to play a supporting role in pre-procedure assessment and post-procedure follow-up, redefining the perioperative experience for both patients and clinicians.

The 2025 tariff adjustments compelled manufacturers and purchasers to restructure supply chains, reprioritize domestic sourcing, and renegotiate procurement strategies across the ecosystem

The introduction of United States tariff measures in 2025 produced a notable, multifaceted impact across the hemorrhoid treatment device ecosystem. For manufacturers that rely on imported components-high-precision optics for laser systems, specialized compressors and gases for cryotherapy, and proprietary disposable dispensers for rubber band ligation-the additional duties increased landed costs and prompted rapid reassessment of sourcing strategies. In response, many suppliers accelerated supplier diversification, sought tariff mitigation through alternate tariff classifications and pursued localized production partnerships to contain margin erosion.

These cost pressures cascaded through distribution channels. Hospital procurement teams intensified negotiations on consumable pricing and service contracts, while some ambulatory centers shifted preference toward devices with lower consumable intensity or with domestic supply footprints. Payers and purchasing coalitions responded by scrutinizing device line-item costs more closely, which in turn influenced product positioning and promotional strategies. Importantly, the tariff environment also adjusted timelines for product launches and upgrades as manufacturers prioritized products with favorable supply chain visibility.

Innovation agendas and go-to-market plans adapted accordingly. Firms with robust in-region manufacturing or assembly capabilities gained advantage in speed-to-market and pricing stability, while smaller manufacturers explored contract manufacturing and licensing to preserve market access. Overall, the tariff developments highlighted the strategic importance of supply chain agility, cost modeling sophistication and proactive engagement with procurement stakeholders across hospitals, clinics and distribution partners.

An integrated segmentation analysis that connects product, end user, distribution and payer distinctions to reveal clinical, logistical, and commercial implications

Product segmentation reveals a broad array of therapeutic approaches and device architectures, with each pathway presenting distinct clinical and commercial implications. Based on Product Type, the market is studied across Cryotherapy Devices, Hemorrhoidectomy Devices, Infrared Coagulation Devices, Laser Treatment Devices, Rubber Band Ligation Devices, and Sclerotherapy Devices. Within cryotherapy, the distinction between gas compression based systems and liquid nitrogen based platforms affects logistics, consumable requirements and site-of-care suitability. Hemorrhoidectomy device variety spans Ligasure devices, stapler devices and traditional scalpel instruments, where differences in procedural complexity, operative time and postoperative outcomes inform hospital and surgeon preferences. Infrared coagulation devices split into contact and non-contact modalities, and laser treatment options include CO2 laser devices, diode laser devices and Nd:YAG laser devices, each offering divergent tissue interaction profiles and capital intensity. Rubber band ligation devices range from disposable dispensers to multi-band, reusable and single-band dispensers, which influence per-case economics and infection control workflows. Sclerotherapy devices are differentiated by Aethoxysklerol syringes and Polidocanol syringes, a distinction that shapes clinical handling, concentration selection and regulatory considerations.

End user segmentation underscores where adoption pressure and investment will concentrate. Based on End User, the market is studied across Ambulatory Surgical Centers, Clinics, Home Care Settings, and Hospitals. Ambulatory surgical centers further bifurcate into hospital-owned and physician-owned entities, each with differing capital approval processes and throughput incentives. Clinics are profiled as general clinics and proctology clinics, where specialized expertise and referral patterns alter procedural mix. Home care settings include nurse-administration and self-administration scenarios, highlighting the growing interest in patient-centric, low-complexity interventions. Hospitals, both private and public, remain focal points for high-acuity cases and for early adoption of capital-intensive platforms.

Distribution and payer segmentation illuminate access and reimbursement dynamics. Based on Distribution Channel, the market is studied across direct sales, hospital purchase, online pharmacies and retail pharmacies, which determine how devices and consumables reach clinicians and patients. Based on Payer Type, the market is studied across government insurance, out-of-pocket and private insurance. Government insurance further segments into Medicaid and Medicare, while out-of-pocket splits into assistance programs and self-pay; private insurance is analyzed in terms of employer-funded plans and individual plans. Together, these segmentation layers frame where clinical adoption, pricing sensitivity and reimbursement engagement will shape commercial success.

How distinct regional regulatory, reimbursement, and manufacturing dynamics across the Americas, Europe Middle East & Africa, and Asia-Pacific influence adoption and commercialization

Regional dynamics create differentiated pathways for technology adoption, evidence requirements and commercial strategy, shaped by regulatory frameworks, payer models and clinical practice patterns. In the Americas, hospital systems and ambulatory surgical centers drive early adoption of minimally invasive platforms where demonstrable cost-of-care advantages align with institutional efficiency goals; close relationships with large group purchasing organizations and integrated delivery networks influence contracting and pricing negotiations.

Across Europe, Middle East & Africa, regulatory harmonization in certain markets coexists with fragmented reimbursement landscapes, prompting manufacturers to pursue targeted clinical evidence and country-specific value dossiers. In some EMEA markets, national procurement programs and centralized tendering favor cost-competitive consumable models, while in other jurisdictions private hospitals and specialized clinics accelerate uptake of premium energy-based devices.

In Asia-Pacific, a heterogeneous mix of mature and rapidly developing healthcare systems creates simultaneous opportunities for high-volume adoption and for innovative distribution partnerships. Manufacturing capacity and regional supply chains in this region support both export-oriented production and local assembly, which can reduce tariff exposure and improve responsiveness to demand volatility. Transitional phrases: collectively, these regional characteristics mean that go-to-market strategies must be tailored to local reimbursement conventions, procurement mechanisms, and the pace of clinical guideline adoption.

Competitive dynamics driven by clinical advocacy, modular innovation, strategic partnerships, and integrated service models that determine differentiation and market traction

The competitive landscape balances entrenched suppliers with agile challengers that emphasize niche innovation, consumable economics and service models. Leading companies invest heavily in clinical evidence generation and user training to lower barriers to adoption, while emerging firms concentrate on modular devices, single-use consumables and digital augmentation to differentiate their offerings. Strategic partnerships, co-development agreements and selective licensing deals are common pathways for extending portfolios without the full capital burden of vertical integration.

Companies that excel combine strong clinical advocacy with flexible commercial models, offering trial programs, bundled consumable pricing and integrated maintenance services. They also prioritize after-sales support and localized training to shorten learning curves for surgeons and clinic staff. In addition, robust supply chain networks and regional assembly facilities provide competitive advantages in markets affected by tariff shifts or logistics constraints.

Finally, M&A activity and targeted investments in adjacent technologies-such as energy delivery modules, disposable applicators and telehealth-enabled follow-up solutions-signal an appetite to broaden clinical utility and capture more of the peri-procedural value chain. These strategic moves reflect a market where differentiation increasingly rests on integrated solutions that connect device performance, clinical outcomes and total cost of care.

Practical strategic recommendations for manufacturers and stakeholders to align product design, evidence generation, distribution, and supply chain resilience for sustained market success

Industry leaders should prioritize a multi-faceted strategy that aligns product design, evidence generation and commercial execution to secure durable competitive advantage. First, focus product development on reducing procedural complexity and consumable intensity while preserving or improving clinical outcomes, enabling broader adoption across ambulatory and clinic settings. Simultaneously, invest in pragmatic clinical studies and real-world evidence that demonstrate shorter recovery times, fewer complications and lower downstream utilization to satisfy payers and procurement committees.

Second, redesign distribution and pricing models to reflect site-of-care economics. Offer flexible contracting, consumable bundles and pilot programs that lower adoption friction for ambulatory surgical centers, physician-owned facilities and clinics. Engage early with hospital procurement groups to align on total cost of ownership and to negotiate service-level agreements that include training and maintenance.

Third, shore up supply chain resilience by diversifying component suppliers, pursuing regional assembly and exploring creative tariff mitigation tactics. Fourth, build scalable training and digital support programs-virtual simulation, procedure libraries and tele-mentoring-that accelerate clinician proficiency and foster product loyalty. Lastly, pursue partnerships that expand clinical indications or integrate complementary technologies, and maintain active dialogue with regulators and payers to shape favorable adoption pathways and reimbursement recognition.

A transparent mixed-methods research approach combining expert interviews, secondary evidence synthesis, and triangulation to deliver reproducible strategic insights

The research underpinning this report combines primary qualitative interviews, secondary data synthesis and rigorous triangulation to ensure reliability and contextual relevance. Primary research included structured interviews with clinical specialists, procurement leaders, ambulatory center administrators and device executives to capture current practice patterns, purchasing priorities and innovation roadmaps. These interviews informed thematic coding that highlighted clinical drivers, adoption barriers and service unmet needs.

Secondary research consolidated peer-reviewed clinical literature, public regulatory filings, product manuals and company disclosures to validate technical claims and to map device feature sets. The analysis employed cross-validation techniques to reconcile differing source perspectives and to identify consistent signals across geographies and end-user types. In addition, subject matter experts reviewed draft findings to detect factual gaps and to confirm practical implications for commercialization and clinical adoption.

Limitations are acknowledged where primary access is constrained, such as in proprietary contract terms and in rapidly evolving tariff frameworks. To mitigate these constraints, sensitivity checks and scenario-based assessments were applied. The methodology emphasizes transparency, reproducibility and a clear link between evidence sources and analytical conclusions to support confident strategic decision making.

A strategic conclusion emphasizing the necessity of evidence-driven innovation, adaptable commercialization, and supply chain agility to capture long-term adoption

In conclusion, the hemorrhoid treatment device arena is undergoing a substantive reorientation driven by technology diversification, shifting site-of-care preferences and strengthened expectations for cost-effective outcomes. Minimally invasive modalities and consumable-efficient devices are gaining traction as clinicians and purchasers seek interventions that reduce recovery time and downstream resource use. Concurrently, supply chain dynamics and tariff developments underscore the need for manufacturing flexibility and nuanced pricing strategies.

Manufacturers that align product innovation with robust clinical evidence, adaptable commercial models and resilient sourcing will be best positioned to capture durable adoption across hospitals, ambulatory surgical centers, clinics and home care settings. Strategic emphasis on clinician training, payer engagement and integrated service offerings will accelerate uptake and foster long-term partnerships. Ultimately, success will favor those organizations that combine clinical credibility with pragmatic operational execution to meet the evolving demands of providers and patients.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Increasing adoption of single-use radiofrequency ablation devices for office-based hemorrhoid treatment
  • 5.2. Expansion of over-the-counter topical cream kits with enhanced biosynthetic polymeric sealants for symptom relief
  • 5.3. Integration of artificial intelligence-driven imaging and diagnostic tools in minimally invasive hemorrhoid therapy devices
  • 5.4. Growing investment in drug-coated stapler systems offering combined surgical resection and localized drug delivery
  • 5.5. Emergence of patient-centric telehealth platforms paired with guided at-home hemorrhoidal banding systems

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Hemorrhoid Treatment Devices Market, by Product Type

  • 8.1. Cryotherapy Devices
    • 8.1.1. Gas Compression Based
    • 8.1.2. Liquid Nitrogen Based
  • 8.2. Hemorrhoidectomy Devices
    • 8.2.1. Ligasure Devices
    • 8.2.2. Stapler Devices
    • 8.2.3. Traditional Scalpel Instruments
  • 8.3. Infrared Coagulation Devices
    • 8.3.1. Contact Infrared Coagulation
    • 8.3.2. Non-Contact Infrared Coagulation
  • 8.4. Laser Treatment Devices
    • 8.4.1. CO2 Laser Devices
    • 8.4.2. Diode Laser Devices
    • 8.4.3. Nd:YAG Laser Devices
  • 8.5. Rubber Band Ligation Devices
    • 8.5.1. Disposable Dispensers
    • 8.5.2. Multi-Band Dispensers
    • 8.5.3. Reusable Dispensers
    • 8.5.4. Single-Band Dispensers
  • 8.6. Sclerotherapy Devices
    • 8.6.1. Aethoxysklerol Syringes
    • 8.6.2. Polidocanol Syringes

9. Hemorrhoid Treatment Devices Market, by End User

  • 9.1. Ambulatory Surgical Centers
    • 9.1.1. Hospital-Owned ASC
    • 9.1.2. Physician-Owned ASC
  • 9.2. Clinics
    • 9.2.1. General Clinics
    • 9.2.2. Proctology Clinics
  • 9.3. Home Care Settings
    • 9.3.1. Nurse-Administration
    • 9.3.2. Self-Administration
  • 9.4. Hospitals
    • 9.4.1. Private Hospitals
    • 9.4.2. Public Hospitals

10. Hemorrhoid Treatment Devices Market, by Distribution Channel

  • 10.1. Direct Sales
  • 10.2. Hospital Purchase
  • 10.3. Online Pharmacies
  • 10.4. Retail Pharmacies

11. Hemorrhoid Treatment Devices Market, by Payer Type

  • 11.1. Government Insurance
    • 11.1.1. Medicaid
    • 11.1.2. Medicare
  • 11.2. Out-of-Pocket
    • 11.2.1. Assistance Programs
    • 11.2.2. Self-Pay
  • 11.3. Private Insurance
    • 11.3.1. Employer-Funded Plans
    • 11.3.2. Individual Plans

12. Hemorrhoid Treatment Devices Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Hemorrhoid Treatment Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Hemorrhoid Treatment Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Johnson & Johnson
    • 15.3.2. Medtronic plc
    • 15.3.3. B. Braun Melsungen AG
    • 15.3.4. CONMED Corporation
    • 15.3.5. Teleflex Incorporated
    • 15.3.6. Olympus Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PAYER TYPE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PAYER TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. HEMORRHOID TREATMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. HEMORRHOID TREATMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. HEMORRHOID TREATMENT DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CRYOTHERAPY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CRYOTHERAPY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CRYOTHERAPY DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CRYOTHERAPY DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CRYOTHERAPY DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CRYOTHERAPY DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CRYOTHERAPY DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CRYOTHERAPY DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY GAS COMPRESSION BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY GAS COMPRESSION BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY GAS COMPRESSION BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY GAS COMPRESSION BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY GAS COMPRESSION BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY GAS COMPRESSION BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY LIQUID NITROGEN BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY LIQUID NITROGEN BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY LIQUID NITROGEN BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY LIQUID NITROGEN BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY LIQUID NITROGEN BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY LIQUID NITROGEN BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HEMORRHOIDECTOMY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HEMORRHOIDECTOMY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HEMORRHOIDECTOMY DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HEMORRHOIDECTOMY DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HEMORRHOIDECTOMY DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HEMORRHOIDECTOMY DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HEMORRHOIDECTOMY DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HEMORRHOIDECTOMY DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY LIGASURE DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY LIGASURE DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY LIGASURE DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY LIGASURE DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY LIGASURE DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY LIGASURE DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY STAPLER DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY STAPLER DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY STAPLER DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY STAPLER DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY STAPLER DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY STAPLER DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY TRADITIONAL SCALPEL INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY TRADITIONAL SCALPEL INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY TRADITIONAL SCALPEL INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY TRADITIONAL SCALPEL INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY TRADITIONAL SCALPEL INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY TRADITIONAL SCALPEL INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY INFRARED COAGULATION DEVICES, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY INFRARED COAGULATION DEVICES, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY INFRARED COAGULATION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY INFRARED COAGULATION DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY INFRARED COAGULATION DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY INFRARED COAGULATION DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY INFRARED COAGULATION DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY INFRARED COAGULATION DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CONTACT INFRARED COAGULATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CONTACT INFRARED COAGULATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CONTACT INFRARED COAGULATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CONTACT INFRARED COAGULATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CONTACT INFRARED COAGULATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CONTACT INFRARED COAGULATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY NON-CONTACT INFRARED COAGULATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY NON-CONTACT INFRARED COAGULATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY NON-CONTACT INFRARED COAGULATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY NON-CONTACT INFRARED COAGULATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY NON-CONTACT INFRARED COAGULATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY NON-CONTACT INFRARED COAGULATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY LASER TREATMENT DEVICES, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY LASER TREATMENT DEVICES, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY LASER TREATMENT DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY LASER TREATMENT DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY LASER TREATMENT DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY LASER TREATMENT DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY LASER TREATMENT DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY LASER TREATMENT DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CO2 LASER DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CO2 LASER DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CO2 LASER DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CO2 LASER DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CO2 LASER DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CO2 LASER DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY DIODE LASER DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY DIODE LASER DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY DIODE LASER DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY DIODE LASER DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY DIODE LASER DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY DIODE LASER DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY ND:YAG LASER DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY ND:YAG LASER DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY ND:YAG LASER DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY ND:YAG LASER DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY ND:YAG LASER DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY ND:YAG LASER DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY RUBBER BAND LIGATION DEVICES, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY RUBBER BAND LIGATION DEVICES, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY RUBBER BAND LIGATION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY RUBBER BAND LIGATION DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY RUBBER BAND LIGATION DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY RUBBER BAND LIGATION DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY RUBBER BAND LIGATION DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY RUBBER BAND LIGATION DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY DISPOSABLE DISPENSERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY DISPOSABLE DISPENSERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY DISPOSABLE DISPENSERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY DISPOSABLE DISPENSERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY DISPOSABLE DISPENSERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY DISPOSABLE DISPENSERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY MULTI-BAND DISPENSERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY MULTI-BAND DISPENSERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY MULTI-BAND DISPENSERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY MULTI-BAND DISPENSERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY MULTI-BAND DISPENSERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY MULTI-BAND DISPENSERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY REUSABLE DISPENSERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY REUSABLE DISPENSERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY REUSABLE DISPENSERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY REUSABLE DISPENSERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY REUSABLE DISPENSERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY REUSABLE DISPENSERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY SINGLE-BAND DISPENSERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY SINGLE-BAND DISPENSERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY SINGLE-BAND DISPENSERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY SINGLE-BAND DISPENSERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY SINGLE-BAND DISPENSERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY SINGLE-BAND DISPENSERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY SCLEROTHERAPY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY SCLEROTHERAPY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY SCLEROTHERAPY DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY SCLEROTHERAPY DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY SCLEROTHERAPY DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY SCLEROTHERAPY DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY SCLEROTHERAPY DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY SCLEROTHERAPY DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY AETHOXYSKLEROL SYRINGES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY AETHOXYSKLEROL SYRINGES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY AETHOXYSKLEROL SYRINGES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY AETHOXYSKLEROL SYRINGES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY AETHOXYSKLEROL SYRINGES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY AETHOXYSKLEROL SYRINGES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY POLIDOCANOL SYRINGES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY POLIDOCANOL SYRINGES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY POLIDOCANOL SYRINGES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY POLIDOCANOL SYRINGES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY POLIDOCANOL SYRINGES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY POLIDOCANOL SYRINGES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOSPITAL-OWNED ASC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOSPITAL-OWNED ASC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOSPITAL-OWNED ASC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOSPITAL-OWNED ASC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOSPITAL-OWNED ASC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOSPITAL-OWNED ASC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PHYSICIAN-OWNED ASC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PHYSICIAN-OWNED ASC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PHYSICIAN-OWNED ASC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PHYSICIAN-OWNED ASC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PHYSICIAN-OWNED ASC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PHYSICIAN-OWNED ASC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY GENERAL CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY GENERAL CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY GENERAL CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY GENERAL CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY GENERAL CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY GENERAL CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PROCTOLOGY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PROCTOLOGY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PROCTOLOGY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PROCTOLOGY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PROCTOLOGY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PROCTOLOGY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY NURSE-ADMINISTRATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY NURSE-ADMINISTRATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY NURSE-ADMINISTRATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY NURSE-ADMINISTRATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY NURSE-ADMINISTRATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY NURSE-ADMINISTRATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY SELF-ADMINISTRATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY SELF-ADMINISTRATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY SELF-ADMINISTRATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY SELF-ADMINISTRATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY SELF-ADMINISTRATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY SELF-ADMINISTRATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOSPITAL PURCHASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOSPITAL PURCHASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOSPITAL PURCHASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOSPITAL PURCHASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOSPITAL PURCHASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOSPITAL PURCHASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PAYER TYPE, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PAYER TYPE, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY GOVERNMENT INSURANCE, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY GOVERNMENT INSURANCE, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY GOVERNMENT INSURANCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY GOVERNMENT INSURANCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY GOVERNMENT INSURANCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY GOVERNMENT INSURANCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY GOVERNMENT INSURANCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY GOVERNMENT INSURANCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY MEDICAID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY MEDICAID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY MEDICAID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY MEDICAID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY MEDICAID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY MEDICAID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY MEDICARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY MEDICARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY MEDICARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY MEDICARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY MEDICARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY MEDICARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 281. GL